Could obesity drugs help with alcohol cravings? New study suggests potential

Advertisement

Advertise with us

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.

Read this article for free:

or

Already have an account? Log in here »

To continue reading, please subscribe:

Subscribe and receive a limited-edition Free Press branded hat or tote.

Digital Subscription

One year of digital access for only $205*

  • Enjoy unlimited reading on winnipegfreepress.com
  • Read the E-Edition, our digital replica newspaper
  • Access News Break, our award-winning app
  • Play interactive puzzles

*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.

To continue reading, please subscribe:

Add Free Press access to your Brandon Sun subscription for only an additional

$1 for the first 4 weeks*

  • Enjoy unlimited reading on winnipegfreepress.com
  • Read the E-Edition, our digital replica newspaper
  • Access News Break, our award-winning app
  • Play interactive puzzles
Start now

*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.

Hey there, time traveller!
This article was published 12/02/2025 (540 days ago), so information in it may no longer be current.

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.

The study was small — just 48 adults — and lasted just over two months, so it’s not the final word. Experts say it’s not yet clear how safe these drugs are for people who don’t need to lose weight.

But the results add to evidence from animal studies and reports that people are finding drugs like Ozempic and Wegovy helpful to manage cravings, not just for food, but also for tobacco and alcohol. Scientists are studying these drugs in smokers, people with opioid addiction and cocaine users.

FILE - A woman holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on March 1, 2024. (AP Photo/Amanda Andrade-Rhoades, File)
FILE - A woman holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on March 1, 2024. (AP Photo/Amanda Andrade-Rhoades, File)

“This is such promising data. And we need more of it,” said study co-author Dr. Klara Klein, of the University of North Carolina at Chapel Hill, who treats patients with diabetes and obesity. “We frequently will hear that once people start these medications that their desire to drink is very reduced, if not completely abolished.”

The drugs, known as GLP-1 receptor agonists, work by mimicking hormones in the gut and the brain to regulate appetite and feelings of fullness. The new study looked at one of these drugs, semaglutide, which is the drug in Ozempic and Wegovy.

The research, published Wednesday in the journal JAMA Psychiatry, was funded by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.

There are already three medications approved to treat alcohol use disorder, so until larger studies can confirm the findings, people should talk to their doctor about what’s already available, said lead author Christian Hendershot, an addiction researcher at University of Southern California.

For the new study, researchers recruited people who reported symptoms of alcohol use disorder, such as difficulty controlling their drinking, but weren’t actively seeking treatment for it.

First, each person came to a lab where they were served their favorite alcoholic beverage and could drink as much as they wanted over two hours.

Then, researchers randomly assigned half the people to get a weekly injection of semaglutide. The other half got sham injections.

For nine weeks, everyone kept track of their drinking habits and their desire for alcohol. A lab visit with their favorite alcohol was repeated at the end of the study.

During the last weeks of the study, nearly 40% in the semaglutide group reported no heavy drinking days compared with 20% in the placebo group. And in the final lab test, the semaglutide group drank roughly half the amount, on average, compared to those who got the placebo.

Everyone in the study was overweight. It’s unclear how safe the drugs would be for a person of normal weight, Klein said.

Smokers in the study who got the semaglutide also cut back on cigarettes, noted Luba Yammine of UTHealth Houston, who is leading other research on GLP-1 drugs for people who want to quit smoking. The finding is promising but more data is needed, Yammine said.

The study “provides additional important information on the potential role of this new class of medications” in treating certain addictions, said Dr. Lorenzo Leggio, an NIH researcher who is leading a 20-week trial of semaglutide for alcohol use disorder now underway in Baltimore.

“It is important to keep in mind that we need larger randomized clinical trials to confirm these findings,” Leggio said.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

Report Error Submit a Tip

More Stories

Steinbach ER nurses ask for triage help as wait-averse Winnipeg patients strain hospital capacity

Nicole Buffie 5 minute read Preview

Steinbach ER nurses ask for triage help as wait-averse Winnipeg patients strain hospital capacity

Nicole Buffie 5 minute read Tuesday, Aug. 4, 2026

Forty nurses from the hospital’s emergency department signed an open letter stating because of the current staffing ratio, nurses are witnessing “excessive and unacceptable safety risks on a daily basis.”

Read
Tuesday, Aug. 4, 2026

Federal government to build $267-M emergency research lab in Winnipeg

Chris Kitching 6 minute read Preview

Federal government to build $267-M emergency research lab in Winnipeg

Chris Kitching 6 minute read Updated: Yesterday at 4:42 PM CDT

The federal government says it will build a $267-million medical countermeasures laboratory in Winnipeg with the goal of preparing Canada for future pandemics or outbreaks.

Expected to open in 2033, the national site will help the country develop vaccines, therapeutics and diagnostic tools, Winnipeg Liberal MP Terry Duguid said.

“This is a big deal for our city and for our province, a big deal for life sciences in Canada,” he told reporters Wednesday. “This facility is going to help protect the nation and help protect the world.”

Ottawa said the site — to be located next to the National Microbiology Laboratory’s Canadian Science Centre for Human and Animal Health on Arlington Street, just north of William Avenue — draws on lessons learned during the COVID-19 pandemic.

Read
Updated: Yesterday at 4:42 PM CDT

Could obesity drugs help with alcohol cravings? New study suggests potential

Carla K. Johnson, The Associated Press 4 minute read Preview

Could obesity drugs help with alcohol cravings? New study suggests potential

Carla K. Johnson, The Associated Press 4 minute read Wednesday, Feb. 12, 2025

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.

The study was small — just 48 adults — and lasted just over two months, so it’s not the final word. Experts say it’s not yet clear how safe these drugs are for people who don’t need to lose weight.

But the results add to evidence from animal studies and reports that people are finding drugs like Ozempic and Wegovy helpful to manage cravings, not just for food, but also for tobacco and alcohol. Scientists are studying these drugs in smokers, people with opioid addiction and cocaine users.

“This is such promising data. And we need more of it,” said study co-author Dr. Klara Klein, of the University of North Carolina at Chapel Hill, who treats patients with diabetes and obesity. “We frequently will hear that once people start these medications that their desire to drink is very reduced, if not completely abolished."

Read
Wednesday, Feb. 12, 2025

Manitoba Hydro’s $3 billion fossil fuel bet

James Beddome and Kent Elson 5 minute read Preview

Manitoba Hydro’s $3 billion fossil fuel bet

James Beddome and Kent Elson 5 minute read Yesterday at 2:00 AM CDT

Manitoba Hydro plans to spend $3 billion to build three new fossil fuel power generation turbines in 2030. This big bet on fossil fuel generation would be a big mistake for both the planet and Manitoban’s pocketbooks.

Read
Yesterday at 2:00 AM CDT

Transit driver stabbed with syringe by passenger

Tyler Searle 3 minute read Preview

Transit driver stabbed with syringe by passenger

Tyler Searle 3 minute read Updated: Yesterday at 9:16 PM CDT

A Winnipeg Transit driver is recovering in hospital after a passenger stabbed him in the leg with a syringe while riding the bus early Wednesday, the Amalgamated Transit Union says.

The union said the incident occurred shortly before 1 a.m. while the operator was stopped in the northbound lanes of Isabel Street, near William Avenue. A female passenger reached around the driver’s safety shield and stabbed the driver twice before getting off the bus.

The driver was taken to the Seven Oaks Hospital in stable condition, where he is undergoing treatment and further testing, union president James Van Gerwen said in an interview.

“We spoke to the member. He is doing OK, but he is still in the hospital and he is scared — as anybody would be,” Van Gerwen said.

Read
Updated: Yesterday at 9:16 PM CDT

Clearing the deck and filling the seats

Editorial 4 minute read Preview

Clearing the deck and filling the seats

Editorial 4 minute read 2:01 AM CDT

The winds of change are always blowing at Winnipeg’s city hall, but with a civic election looming this fall, the gusts through the council chamber at 510 Main St. seem particularly strong.

With slightly less than three months until voters head to the polls, no less than five incumbent councillors have declared they will not stand for re-election. Combine that with the possibility that one or more other members of the 15-member body could lose their bids for re-election, and what becomes apparent is that the makeup of Winnipeg’s municipal decision-making assembly will have changed dramatically when the new council is sworn in.

The five veteran councillors who have opted not to seek another term are Sherri Rollins (Fort Rouge-East Fort Garry), Markus Chambers (St. Norbert–Seine River), John Orlikow (River Heights-Fort Garry), Janice Lukes (Waverley West) and Brian Mayes (St. Vital).

All the departing councillors are experienced representatives, with Rollins and Chambers having served two terms, Lukes having been on council for a dozen years, and Mayes and Orlikow having served 15 and 17 years respectively. Had any or all of them chosen to run again, they would almost certainly have been re-elected, as incumbency remains a most formidable force in municipal politics.

Read
2:01 AM CDT